Pegasus LifeSciences is a boutique consultancy that specializesin transforming innovations into life-changing products. We help innovators and early-stage companies take their products froman idea to a marketable product.
Unlike large consulting practices, where you often get sold by a senior person and then assigned a junior person, at Pegasus you are guaranteed senior level experience. Having founded companies, we understand the challenges and we respect ALL founders. We understand what it takes to start and exit a LifeSciences Company (because we have done it).

Who We Are
The Pegasus LifeSciences Team
Karen Heart

CLINICAL STRATEGY & MEDICAL OPERATIONS
-
Clinical Operations Head: From study design to FDA clearance
-
Medical Operations team lead build for launch and management
-
Over 30 years in Pharmaceutical and Medical Device Companies
-
Large Company Experience: Wyeth Pharmaceuticals
-
Start-Up Experience: Beraterin, Advicenne, Neuronetics
-
Clinical Regulatory Head through IPO at Neuronetics
-
Help to grow departments, address efficiencies of processes, human resources, and use of vendors
-
MBA St. Joseph's University, BS Juniata College
Cassie Halberg

COMMERCILIZATION LEADER
-
25+ years in CPG, OTC, Pharma, & Medical Device Sales & Marketing
-
8 years of C-Suite experience.
-
Large Company Experience: Johnson & Johnson, Janssen, Sanofi, Nabisco
-
Start-Up Experience: SonikHealth, Neocis, Neuronetics (STIM), Insight Pharmaceuticals
-
2 successful exits including helping to take Neuronetics (STIM) public in 2018
-
Grew Neuronetics's annual company revenues from $21 million to $52.8 million. 36% CAGR over 3 years.
-
Coach for CT’s Bio Accelerator ABCT, NYC E-Labs, Westchester County Catalyst Bio Accelerator
-
MBA UC Berkeley Haas School of Business, BA University of Chicago
Michael Carson

CFO/FINANCIAL STRATEGY
-
18 years of experience in Life Sciences
-
Executed an oversubscribed Series A extension, successfully expanding the
investor syndicate by three firms while delivering $22.6M to drive
market expansion, clinical trials, and manufacturing improvements. -
Orchestrated and managed multiple banking relationships to drive flexibility and liquidity while implementing a defined investment policy, increasing
the rate of return by 150%. -
Successfully scaled a private company valued at $60M to a publicly traded
company with a $500M market capitalization in under 3 years. -
Managed a complex close process in 3 days for a division valued at over $800M in revenue with manufacturing sites across Latin America, Eastern Europe, and Asia.
-
Played an integral role in three successful IPOs, establishing investment policies to help founders capture and maximize financial returns.
-
Large Company Experience: Abbott and Deloitte
-
Start-Up Experience: XyloCor, Smith's Medical, Neuronetics
-
C.P.A, B.A. Economics & Accounting, B.S. Mechanical Engineering Lafayette College